OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural killer cell immunotypes related to COVID-19 disease severity
Christopher Maucourant, Iva Filipovic, Andrea Ponzetta, et al.
Science Immunology (2020) Vol. 5, Iss. 50
Open Access | Times Cited: 430

Showing 1-25 of 430 citing articles:

Diverse functional autoantibodies in patients with COVID-19
Eric Y. Wang, Tianyang Mao, Jon Klein, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 283-288
Open Access | Times Cited: 825

SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 699

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
Yapeng Su, Daniel Chen, Dan Yuan, et al.
Cell (2020) Vol. 183, Iss. 6, pp. 1479-1495.e20
Open Access | Times Cited: 552

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F. Osuchowski, Martin Sebastian Winkler, Tomasz Skirecki, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 622-642
Open Access | Times Cited: 476

Natural killer cells in antiviral immunity
Niklas K. Björkström, Benedikt Strunz, Hans‐Gustaf Ljunggren
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 112-123
Open Access | Times Cited: 353

COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung, Melissa N. Thone, Young Jik Kwon
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 1-25
Open Access | Times Cited: 352

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 1, pp. e1009195-e1009195
Open Access | Times Cited: 297

Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Shea A. Lowery, Alan Sariol, Stanley Perlman
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1052-1062
Open Access | Times Cited: 261

Unique immunological profile in patients with COVID-19
Stefania Varchetta, Dalila Mele, Barbara Oliviero, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 3, pp. 604-612
Open Access | Times Cited: 242

Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Can Liu, Andrew J. Martins, William Lau, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1836-1857.e22
Open Access | Times Cited: 207

Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
Mario Witkowski, Caroline Tizian, Marta Ferreira‐Gomes, et al.
Nature (2021) Vol. 600, Iss. 7888, pp. 295-301
Closed Access | Times Cited: 201

Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Immunity (2021) Vol. 54, Iss. 11, pp. 2650-2669.e14
Open Access | Times Cited: 193

MAIT cell activation and dynamics associated with COVID-19 disease severity
Tiphaine Parrot, Jean‐Baptiste Gorin, Andrea Ponzetta, et al.
Science Immunology (2020) Vol. 5, Iss. 51
Open Access | Times Cited: 185

Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19
Aaron J. Wilk, Madeline Lee, Bei Wei, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 8
Open Access | Times Cited: 183

Innate immunological pathways in COVID-19 pathogenesis
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 160

Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 32-50
Open Access | Times Cited: 151

Human NK cells, their receptors and function
Linda Quatrini, Mariella Della Chiesa, Simona Sivori, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1566-1579
Open Access | Times Cited: 122

Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19
Hannes Vietzen, Alexander Zoufaly, Marianna Traugott, et al.
Genetics in Medicine (2021) Vol. 23, Iss. 5, pp. 963-967
Open Access | Times Cited: 115

Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19
Anna H.E. Roukens, Cilia R. Pothast, Marion König, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 23-32
Open Access | Times Cited: 109

A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
Ren Yang, Yao Deng, Baoying Huang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 107

SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells
Nicolas Huot, Cyril Planchais, Pierre Rosenbaum, et al.
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 2068-2079
Open Access | Times Cited: 43

Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer
Aristo Vojdani, Sadi Köksoy, Elroy Vojdani, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 230-230
Open Access | Times Cited: 20

Advances and Challenges in Sepsis Management: Modern Tools and Future Directions
Elena Santacroce, Miriam D’Angerio, Alin Liviu Ciobanu, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 439-439
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top